Prognostic Factors for All Types of Cancer Combined
This trial is active, not recruiting.
|Sponsor||Atrium Medical Center|
|Collaborator||Maastricht University Medical Center|
|Start date||November 2006|
|End date||June 2015|
|Trial size||520 participants|
|Trial identifier||NCT00704587, MEC 08-02-030, METC 06-p-47, NL14215.096.06, ProFaCo|
The purpose of this study is to investigate every possible applicability of flow cytometrical analysis in the intracellular detection of tumor-related material in activated macrophages in the broadest range of cancer types.
|United States||No locations recruiting|
|Other countries||No locations recruiting|
|Observational model||case control|
screening and followup
time frame: 2 years
Male or female participants at least 18 years old.
Inclusion Criteria: - (Suspicion of) presence of cancer in the broadest sense of the word - Must be able to understand and sign written informed consent Exclusion Criteria: - None
|Official title||Flow Cytometrical Analysis of the Human Immune System to Assess Tumor-related Material Piling up in Activated Macrophages in All Relevant Cancer Types.|
|Principal investigator||Dennis Japink, MD|
Call for more information